March 23, 2023
Pfizer Japan began the commercial rollout of its oral COVID-19 treatment Paxlovid (nirmatrelvir/ritonavir) on March 22, making it available under the normal wholesaler distribution channel in the country. In Japan, the company earned special approval for Paxlovid Pack in February...read more